Serbia to make lab tests of Russia's COVID-19 vaccine - statement

FILE PHOTO: A nurse prepares Russia's "Sputnik-V" vaccine against the coronavirus disease (COVID-19) for inoculation at a clinic in Tver, Russia, October 12, 2020. REUTERS/Tatyana Makeyeva

BELGRADE (Reuters) - Serbia plans to start laboratory testing of Russia's Sputnik V vaccine against the coronavirus and it will also continue talks with drugmaker Pfizer Inc about purchasing its shot, the country's prime minister said on Monday.

Russia will deliver 20 doses of its vaccine to Serbia for laboratory testing by the end of the week, the office of Prime Minister Ana Brnabic said in a statement after speaking via videoconference with Russia's trade and industry minister Denis Manturov.

"Serbia is interested in ... a possibility of a joint production of the vaccine," the statement said.

Russia has said interim trial results show its vaccine to be 92% effective at protecting people from COVID-19.

The statement also said Brnabic will continue talks with Pfizer on Tuesday. It offered no further details.

Before Serbia adopts any vaccine, it must be approved by the country's Medicines and Medical Devices Agency.

So far 175,438 people have fallen ill with COVID-19 in Serbia, which has a population of 7.2 million, and 1,604 have died from it.

(Reporting by Aleksandar Vasovic in Belgrade; Editing by Matthew Lewis)

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 18
Cxense type: free
User access status: 3

Did you find this article insightful?


100% readers found this article insightful

Next In World

Exclusive: U.N. report accuses Yemen government of money-laundering, Houthis of taking state revenue
Israel reports 7,889 new COVID-19 cases, 613,286 in total
Service sector in U.S. Texas flat in January: survey
Finnish Viking Line welcomes launch of its new cruise ship built in China
Zoom and Google outages roil work-from-home economy in US
G7 calls for peaceful Navalny protesters to be released by Russia
Bilateral vaccine deals putting WHO-led COVAX at risk: Tedros
NYC COVID-19 test positivity rate down to 8.4 pct, new cases up to 4,844: mayor
Finnish economy likely to grow by 3 pct in 2021: OP Financial Group
Lebanon reports highest 73 daily COVID-19 deaths

Stories You'll Enjoy